Palbociclib Hydrochloride (20:37), sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride (20:37) API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Palbociclib Hydrochloride (20:37)
Catalogue No.:PA 16 4130000
CAS :
Molecular Formula : 20(C24H29N7O2) . 37(HCl)
Molecular Weight : 20(447.54) + 37(36.46)
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
